Estrogen receptor α gene polymorphism and vascular complications in girls with type 1 diabetes mellitus

Mol Cell Biochem. 2018 Jan;437(1-2):153-161. doi: 10.1007/s11010-017-3103-0. Epub 2017 Jun 20.

Abstract

The effect of estrogens is mediated by activation of estrogen receptors (ERs). Because ER-α gene polymorphisms may exert different effects in childhood, we analyzed the associations between the IVS1 -397T>C (PvuII) polymorphism and systemic inflammatory state, proangiogenic factors, frequency of monocyte subsets, lipid profile, blood pressure, and vascular complications in girls with type 1 diabetes mellitus (DM1). We examined 180 young girls with DM1 and 120 healthy age-matched controls. The analysis concerned PvuII polymorphism of the ER-α gene as well as the levels of serum inflammatory markers (CRP, IL-6, TNF-α), proangiogenic factors (VEGF, angiogenin), 17β-estradiol, values of monocyte subsets (CD14++CD16- and CD14+CD16+), lipid profile, and blood pressure. In our study, girls with CC genotype had lower level of inflammatory and angiogenic factors and lower frequencies of CD14+CD16+ monocytes in comparison to CT or TT carriers. Simultaneously, the CC carriers had a greater population of CD14++CD16- monocytes, increased blood pressure, and serum levels of: estrogen, total cholesterol, triglycerides, and low-density lipoprotein cholesterol than girls bearing CT or TT genotype. Our study suggests a pleiotropic effect of PvuII polymorphic CC variant on diabetic vasculopathies. Although the CC genotype carriers demonstrate less inflammatory and angiogenic activity, they seem to display less favorable cardiometabolic features. Based on our study, we cannot distinguish PvuII ER-α genotype that could be useful in identification of DM1 girls that are more prone to develop of late vascular complications, before the occurrence of first clinical symptoms.

Keywords: Angiogenic factors; CD16; Diabetes-related vascular complications; Estrogen receptor α gene polymorphism; Inflammation; Serum lipid profile.

Publication types

  • Clinical Trial

MeSH terms

  • Adolescent
  • Adult
  • Biomarkers / blood
  • Diabetes Mellitus, Type 1 / blood
  • Diabetes Mellitus, Type 1 / genetics*
  • Diabetic Angiopathies / blood
  • Diabetic Angiopathies / genetics*
  • Estrogen Receptor alpha / blood
  • Estrogen Receptor alpha / genetics*
  • Female
  • Humans
  • Inflammation Mediators / blood
  • Polymorphism, Genetic*

Substances

  • Biomarkers
  • ESR1 protein, human
  • Estrogen Receptor alpha
  • Inflammation Mediators